SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / March 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or “the Company”) today issued a reminder that today, March 2, 2026, is the Record Date for ...
Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force SAN FRANCISCO, CA / ACCESSWIRE ...
Jaguar received an up-front payment of $16Mof non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi ® and Canalevia ®-CA1 – Jaguar’s commercialized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results